Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Asklepion AS
AS
Active
Org 913018680
Konglefaret 38, 1359
Eiksmarka
Medical specialists activities
·
NACE 8622
Est. 2014 · 12 years old
15 employees
Monitor
Share
Norway
/
Companies
/
Medical specialists activities
/
Asklepion AS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
NOK millions
11M
8M
6M
3M
0M
2020: 7M
7M
2020
2021: 8M (+14% vs 2020)
8M
+14%
2021
2022: 8M (0% vs 2021)
8M
0%
2022
2023: 9M (+13% vs 2022)
9M
+13%
2023
2024: 9M (0% vs 2023)
9M
0%
2024
EBITDA
NOK millions
5M
4M
2M
1M
0M
2020: 3M
3M
2020
2021: 3M (0% vs 2020)
3M
0%
2021
2022: 4M (+33% vs 2021)
4M
+33%
2022
2023: 4M (0% vs 2022)
4M
0%
2023
2024: 4M (0% vs 2023)
4M
0%
2024
Income statement
NOK thousands
Item
2024
2023
2022
2021
2020
Revenue
9 220
8 758
8 405
7 615
7 418
Staff expenses
−2 612
−2 845
−2 537
−2 253
−2 020
EBITDA
4 188
3 548
3 669
3 153
3 172
Depreciation & amort.
−119
−73
−127
−174
−283
EBIT
4 069
3 476
3 542
2 979
2 889
Net financials
−37
−26
−0
−3
−3
Profit before tax
4 032
3 450
3 542
2 976
2 886
Tax
887
759
782
655
635
Net profit
3 145
2 691
2 760
2 321
2 251
Balance sheet
NOK thousands
Item
2024
2023
2022
2021
2020
Total assets
5 631
5 598
4 147
4 210
4 089
Equity
687
682
591
702
280
Long-term debt
460
857
0
1 957
415
Short-term debt
4 484
4 058
3 556
1 551
3 393
Total debt
4 944
4 916
3 556
3 508
3 808
Financial ratios
5-year trend
EBITDA margin
45,4 %
This company
15,8 %
Market median
This company
Market median
187% above market
2020
2024
Equity ratio
12,2 %
This company
38,2 %
Market median
This company
Market median
68% below market
2020
2024
Return on equity
457,7 %
This company
18,4 %
Market median
This company
Market median
>999% above market
2020
2024
Net profit margin
34,1 %
This company
8,1 %
Market median
This company
Market median
321% above market
2020
2024
Asset turnover
1,64×
This company
1,12×
Market median
This company
Market median
46% above market
2020
2024
Debt / equity
7,19×
This company
0,62×
Market median
This company
Market median
>999% above market
2020
2024
Annual reports & filings
Annual report 2024
Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
View
PDF
More on Asklepion AS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
